Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DL-PDT vs AWL-PDT vs minocycline for papulopustular rosacea
ChiCTR2600116884Phase 4Not yet recruiting
- Sponsor
- Southwest Hospital of Army Medical University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of minocycline and 5-aminolevulinic acid in papulopustular rosacea (3 arms), sponsored by Southwest Hospital of Army Medical University. Primary endpoint: Number of papules and pustules. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
minocycline5-aminolevulinic acid
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on ChiCTR2600116884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116884.